Standout Papers

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494) 2018 2026 2020 2023 261
  1. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494) (2018)
    Julie Parmentier, J W Voss et al. BMC Rheumatology

Immediate Impact

5 by Nobel laureates 12 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Stereoselective amino acid synthesis by photobiocatalytic oxidative coupling
2024 StandoutNature
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
3 intermediate papers

Works of M.A. Argiriadi being referenced

Creation of a S1P Lyase bacterial surrogate for structure-based drug design
2016
Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol
2015

Author Peers

Author Last Decade Papers Cites
M.A. Argiriadi 352 160 177 243 20 942
Barbara A. Domin 498 87 201 88 31 1.1k
A. H. Blair 467 69 151 117 31 1.0k
Peppi Prasit 585 239 124 66 43 1.1k
Martin C. Dyroff 414 53 191 45 29 1.0k
Y. Amano 464 189 67 68 35 787
Rainer N. Zahlten 341 30 98 82 27 788
Tanya Coleman 576 146 276 32 28 1.1k
Denis McCann 561 83 147 40 26 815
Wolfgang A. Schmalix 462 54 172 123 35 1.0k
Anton E.P. Adang 591 224 122 84 26 936

All Works

Loading papers...

Rankless by CCL
2026